{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Melbourne",
      "state": "FL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73560",
      "recalling_firm": "Pacifico National, Inc. dba AmEx Pharmacy",
      "address_1": "1515 Elizabeth St Ste J",
      "address_2": "N/A",
      "postal_code": "32901-3000",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0869-2016",
      "product_description": "Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.",
      "product_quantity": "45 syringes",
      "reason_for_recall": "Non-Sterility: Product tested positive for bacterial contamination.",
      "recall_initiation_date": "20150120",
      "center_classification_date": "20160525",
      "termination_date": "20170309",
      "report_date": "20160601",
      "code_info": "Lot #: 141224C, Exp. 03/24/2015; 150915B, Exp. 12/14/2015"
    }
  ]
}